Zhen Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhen Gao has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Dezhao Tang
Department of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2 shared publications- Guibin Qiao
Department of Thoracic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China
2 shared publications - Sichao Wang
Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
2 shared publications - Abraham Ka Chung Wai
The University of Hong Kong
1 shared publication - Dan-Yang Zheng
Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
1 shared publication - Feng-Ming Kong
Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
1 shared publication
Latest Publications
- Open Access
- 15 February 2026
- Published by Elsevier in Journal of the National Cancer Center
- Vol. 6 (2) , 185-188
Differential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China
- 15 February 2026
- Published by Elsevier in Journal of the National Cancer Center
- Vol. 6 (2) , 185-188
Open AccessDifferential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China
- Open Access
- 14 October 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 39, 100927
Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
- 14 October 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 39, 100927
Open AccessDoes nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
- Open Access
- 6 July 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 38, 100841
Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis
- 6 July 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 38, 100841
Open AccessEfficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis